These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 4179770)

  • 61. Skin tests with nuclear factors in systemic lupus erythematosus.
    Jones HE; Derbes VJ; Gum OB; Azoury FJ
    Arch Dermatol; 1967 Jun; 95(6):559-64. PubMed ID: 5338435
    [No Abstract]   [Full Text] [Related]  

  • 62. Urinary immunoglobulins in rheumatoid arthritis and other connective tissue diseases.
    Lindström FD
    Ann Clin Res; 1971 Feb; 3(1):39-45. PubMed ID: 4100602
    [No Abstract]   [Full Text] [Related]  

  • 63. [Improved method for the detection of antinuclear antibodies using chicken erthrocytes].
    Tsuchiya T; Kawai T; Iwata S
    Igaku To Seibutsugaku; 1968 Oct; 77(4):145-50. PubMed ID: 4885334
    [No Abstract]   [Full Text] [Related]  

  • 64. Immunohistochemical study of lesions in rheumatic fever, systemic lupus ervthematosus, and rheumatoid arthritis.
    VAZQUEZ JJ; DIXON FJ
    Lab Invest; 1957; 6(3):205-17. PubMed ID: 13429841
    [No Abstract]   [Full Text] [Related]  

  • 65. [Antinuclear factors. Clinical and humoral correlations; diagnostic importance].
    Purice S; Gheorghiu M; Ghelerter L; Drăgoi T
    Med Interna (Bucur); 1969 Oct; 21(10):1205-40. PubMed ID: 4189145
    [No Abstract]   [Full Text] [Related]  

  • 66. Antinuclear factors in synovial fluids.
    MacSween RN; Dalakos TK; Jasani MK; Wilson ME; Boyle JA; Buchanan WW; Goudie RB
    Lancet; 1967 Feb; 1(7485):312-4. PubMed ID: 4163515
    [No Abstract]   [Full Text] [Related]  

  • 67. [Routine immunofluorescence examinations for the demonstration of antinuclear factors].
    Hiemann D
    Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:150-1. PubMed ID: 4918616
    [No Abstract]   [Full Text] [Related]  

  • 68. [Antinuclear antibodies and beta1A concentration in systemic lupus erythematosus and other diseases].
    Monegat JN; Joller-Jemelka HI; Grob PJ
    Schweiz Med Wochenschr; 1974 Nov; 104(45):1614-23. PubMed ID: 4612703
    [No Abstract]   [Full Text] [Related]  

  • 69. [Chemotaxis of human polymorphonuclear cells in vitro. Study of inflammatory rheumatic diseases].
    Leimgruber A; Frei PC; Ochsner M; Schubert M; Saudan Y
    Schweiz Med Wochenschr; 1975 Dec; 105(50):1730-2. PubMed ID: 56033
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Quantitative studies of immunofluorescent staining. VI. Defined complement immunofluorescent staining for antinuclear antibodies in systemic lupus and other collagen diseases.
    Diaz Gill GA; Beutner EH; Eisenberg RB
    Int Arch Allergy Appl Immunol; 1973; 45(6):868-79. PubMed ID: 4586867
    [No Abstract]   [Full Text] [Related]  

  • 71. ANTINUCLEAR FACTOR IN SYSTEMIC LUPUS ERYTHEMATOSUS. A CONSIDERATION OF THE IMMUNOFLUORESCENT METHOD OF DETECTING ANTINUCLEAR ANTIBODIES, WITH RESULTS OBTAINED IN A FAMILY STUDY.
    HOLBOROW J; JOHNSON GD
    Arthritis Rheum; 1964 Apr; 7():119-27. PubMed ID: 14150741
    [No Abstract]   [Full Text] [Related]  

  • 72. Clinical significance of antinuclear antibodies.
    Rothfield NF
    J Med Assoc Ga; 1967 Dec; 56(12):491-4. PubMed ID: 4866469
    [No Abstract]   [Full Text] [Related]  

  • 73. [Abnormal findings in the blood in SLE].
    Ofuji T; Miyawaki S; Sato H; Morita M; Nishishita S
    Nihon Rinsho; 1968 Dec; 26(12):3449-58. PubMed ID: 4181084
    [No Abstract]   [Full Text] [Related]  

  • 74. [Demonstration of antinuclear factors using the immunologic enzyme technic].
    Storch H
    Z Gesamte Inn Med; 1973 Jan; 28(2):29-32. PubMed ID: 4120838
    [No Abstract]   [Full Text] [Related]  

  • 75. [Demonstration of increased influenza-A-antibody levels in the serum of patients with chronic polyarthritis].
    Wruck K; Zöller B; Faust-Tinnefeldt G; Engel HJ
    Z Rheumatol; 1985; 44(6):259-62. PubMed ID: 4096127
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The immunofluorescent tumor imprint technique. IV. The significance of "thready" nuclear immunofluorescence.
    Burnham TK; Neblett TR; Fine G; Bank P
    Arch Dermatol; 1969 May; 99(5):611-6. PubMed ID: 4889089
    [No Abstract]   [Full Text] [Related]  

  • 77. Bullous pemphigoid associated with systemic lupus erythematosus.
    Jordon RE; Muller SA; Hale WL; Beutner EH
    Arch Dermatol; 1969 Jan; 99(1):17-25. PubMed ID: 4178218
    [No Abstract]   [Full Text] [Related]  

  • 78. Diagnostic tests for systemic lupus erythematosus.
    Mani RM; Trikannad VS; Batlivala PM; Krishnaswamy PR
    J Assoc Physicians India; 1980 Nov; 28(11):451-5. PubMed ID: 6163759
    [No Abstract]   [Full Text] [Related]  

  • 79. [Rheumatology in 1971-72-73-74].
    Auquier L; Peltier A; Paolaggi JB
    Rev Prat; 1975 Jun; 25(35):2717-51. PubMed ID: 170659
    [No Abstract]   [Full Text] [Related]  

  • 80. A study of antipolynucleotide antibodies, anti-Klebsiella (K30) antibodies and anti-DNA antibody idiotypes in ankylosing spondylitis.
    Isenberg DA; Feldman R; Dudeney C; Konikoff F; Jones D; Ebringer A; Shoenfeld Y
    Br J Rheumatol; 1987 Jun; 26(3):168-71. PubMed ID: 3495312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.